News
The global amyotrophic lateral sclerosis market is on an upward trajectory, demonstrating significant potential for growth and innovation. According to the latest insights from Future Market Insights ...
Prilenia inks agreement with Ferrer to commercialize and co-develop pridopidine in Europe and other select markets: Naarden, Netherlands Tuesday, April 29, 2025, 12:00 Hrs [IST] P ...
An amyotrophic lateral sclerosis (ALS) diagnosis is often viewed as getting a death sentence. After diagnosis, people with ...
Abnormal kinase signaling can promote other harmful traits, such as neuroinflammation and neuronal cell death. On the other ...
Ferrer’s R&D work focuses on neurological and pulmonary diseases, and the Spanish pharma has bought into ALS assets in the ...
Lisa Hughart was a regular at sporting events for the last 30 years, supporting her children, then grandchildren. Dozens of people came to honor her and raise money to fight the deadly disease ...
The guitarist, who also played in the Black Hollies, has also released a solo album recorded shortly before the diagnosis ...
The viral Ice Bucket Challenge originated in 2014 benefiting the ALS Foundation. Now, it's been rebranded to support mental ...
The Ice Bucket Challenge went viral in 2014 as a fundraiser for ALS. Now it’s trending again with a new cause and not ...
TV star Eric Dane is going through a tough present after being diagnosed with amyotrophic lateral sclerosis or also known as ALS. In some patients, his ALS diagnosis may be relate ...
A man with ALS received a Neuralink BCI implant, allowing him to control a laptop cursor and generate his own voice using AI.
Prilenia Therapeutics has entered into a collaboration & license agreement with Ferrer for the commercialization and further development of pridopidine in Europe and other select markets.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results